Arkolith/Insider Trading/CGEM/Form 4

Michaelson Jennifer

Chief Scientific OfficerCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed Jul 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$143K
Net Open-Market Flow
-$143K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 6, 2026Option exercise(M)4K$4.30$17K171K
Jul 6, 2026Sell(S)8K$17.82$143K163K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 6, 2026Option exercise(M)4K—$0113K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-297605) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML